News
-
February 13th, 2024 - GKardia is certified with ISO 13485:2016 και ISO 9001:2015
GKardia confirms the quality of its products and services with the certification according to ISO 13485:2016 and ISO 9001:2015 by the National Center for Quality Assessment and Technology in Health (EKAPTY).
-
February 13th, 2024 – Gkardia expands in Bulgaria
GKardia expands its activity in Bulgaria with an agreement and clinical application of COR-KNOT by the cardiac surgery department of the private hospital ACIBADEM CITYCLINIC.
-
January 16th, 2024 - Exclusive distribution agreement for Greece and Cyprus with Medichema
GΚardia launches its exclusive distribution agreement with Medichema Germany and the two-layer bioabsorbable hemostatic pad Medicipio A for Greece and Cyprus.
-
November 11th, 2023 - Exclusive distribution agreement for Greece and Cyprus with Autotissue
GΚardia launches its collaboration with Autotissue from Germany and the Matrix equine pericardial patch for Congenital and Structural Heart procedures.
-
November 3rd, 2023 – GKardia is expanding sales activities in Cyprus
GKardia expands its activity in Cyprus and the first COR-KNOT clinical applications in surgical valve procedures are introduced at Nicosia General Hospital.
-
April 24th, 2023 - Exclusive distribution agreement for Greece and Cyprus with LSI Solutions INC.
GKardia invoices the first COR-KNOT devices starting the exclusive distribution agreement for Greece and Cyprus with the manufacturer LSI Solutions INC.
-
November 23rd, 2022 – Certification of National Evaluation Center of Quality and Technology in Health S.A
GKardia receives certification from National Evaluation Center of Quality and Technology in Health S.A based on the Interministerial Decision DY8/1348/04 for the distribution of medical devices in Greece.
-
October 20th, 2022 – Establishment of GKardia
Our company, GKardia, is founded by Grigoris(Gregory) Krinos, who decided to create a partnership in the field of Medical Devices, capitalizing on more than 30 years of experience in this field through high level executive positions of increased responsibility in multinational companies.
The exclusive purpose of the company is to collaborate with innovative technologies and products of esteemed medical device manufacturers that will improve and optimize the provision of care and therapies to patients in Southeastern Europe.